Teli

Composition:

  • Telmisartan 

Indication:

  • Used in the management of HTN. 

Dosage:

  • Treatment of essential HTN: 40 mg once daily.

  • Max 80 mg. CV prevention: 80 mg once daily, with or without food. 

Contra Indication:

  • Hypersensitivity. 2nd and 3rd trimester of pregnancy. Biliary obstructive disorders. Hepatic impairment.

  • Primary aldosteronism. Children <18 yrs. 

Precaution:

  • Patients with mild-moderate hepatic impairment. Renovascular HTN.

  • Periodic monitoring of potassium and creatinine serum levels in patients with impaired renal function.

  • Volume and/or sodium depletion should be corrected prior to initiation of therapy. Patients suffering from aortic/mitral stenosis, or obstructive hypertrophic cardiomyopathy. Rare hereditary problems of fructose intolerance.

  • Pregnancy and lactation. 

Drug interaction:

  • Potassium-sparing diuretics or potassium-supplements, Lithium, NSAIDs, diuretics (thiazide or loop), other antihypertensive agents, corticosteroids. 

Preparation:

  • Tab 40mg, 30's.

  • Tab 80mg, 30's